Physician profile
Jack C Leong
NPI 1174506513
$2,447.44
in general payments reported to CMS, 2019-2025
11 companies · $474 in 2025
The $474 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $344 · 2021: $35.64 · 2022: $508 · 2023: $201 · 2024: $728 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,402.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $663.76 | 2020-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $556.38 | 2019-2024 | Arexvy, Shingrix, Bexsero |
| Medtronic, INC. | $285.96 | 2024-2025 | Sonicision, Signia |
| Mimedx Group, INC. | $280.98 | 2024-2025 | |
| Pfizer INC. | $219.68 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $135.95 | 2019 | |
| Sanofi Pasteur INC. | $124.34 | 2022 | |
| Seqirus USA INC | $88.59 | 2022-2024 | Fluad, Flucelvax Quadrivalent, Fluad Quadrivalent |
| Kowa Pharmaceuticals America, INC. | $58.57 | 2024-2025 | Zoryve |
| Biomarin Pharmaceutical INC. | $18.76 | 2024 | Voxzogo 1.2mg |
| Exact Sciences Corporation | $14.47 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Leong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.